Belimumab after B cell depletion therapy in patients with systemic lupus erythematosus (BEAT Lupus) protocol: a prospective multicentre, double-blind, randomised, placebo-controlled, 52-week phase II clinical trial
- Alexis Jones
- , Patrick Muller
- , Caroline Dore
- , Felicia Ikeji
- , Emilia Caverly
- , Kashfia Chowdhury
- , David Isenberg
- , Caroline Gordon
- , Michael Ehrenstein
Research output: Contribution to journal › Article › peer-review
10
Citations
(Scopus)
238
Downloads
(Pure)